Coiled-coil domain-containing 178 (CCDC178) is a protein that, as implied by its name, features a coiled-coil domain, which is a structural motif characterized by the intertwining of two or more alpha-helices into a supercoil structure. This motif is commonly involved in facilitating protein-protein interactions, suggesting that CCDC178 may play a role in a variety of cellular processes through its ability to form complexes with other proteins.The precise biological function of CCDC178 is not fully characterized, but proteins with coiled-coil domains are often implicated in various aspects of cell biology, including vesicle trafficking, cytoskeletal organization, and the regulation of gene expression. CCDC178, by virtue of its domain structure, may similarly be engaged in one or multiple such cellular activities.
The coiled-coil domain typically facilitates the oligomerization of proteins and is involved in the assembly of multiprotein complexes. Therefore, CCDC178 may participate in the formation of structures necessary for maintaining cell shape, intracellular transport, and cell signaling. The protein could be a component of the cytoskeleton or involved in the dynamics of cytoskeleton-associated processes, such as mitosis or cell motility.Given the general role of coiled-coil domain-containing proteins, CCDC178 might also be involved in intracellular trafficking pathways, such as the transport of vesicles between organelles like the Golgi apparatus and the plasma membrane. This process is critical for the secretion of proteins and lipids and for the retrieval of membrane components.Mutations or alterations in the expression of genes encoding coiled-coil domain proteins can have significant effects on cellular function and have been associated with various diseases. As such, understanding the specific interactions and functions of CCDC178 could have implications for the study of diseases where protein aggregation, trafficking, and cellular architecture are disrupted.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in cell growth and proliferation. As CCDC178 might be involved in similar pathways, mTOR inhibition could indirectly affect processes where CCDC178 plays a role. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis in eukaryotic organisms. If CCDC178 is involved in protein synthesis regulation or dependent pathways, its function might be indirectly influenced by this inhibitor. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. It alters chromatin structure and gene expression. As CCDC178 expression might be regulated epigenetically, this inhibitor could indirectly affect its expression levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. Given that PI3K is involved in numerous signaling pathways, including those related to cell growth and survival, it could indirectly impact the function of CCDC178. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. This kinase is involved in inflammatory responses and stress signaling, potentially interacting with pathways where CCDC178 is involved. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits proteasome activity. If CCDC178 is involved in protein degradation pathways or is regulated by ubiquitination, this inhibitor could indirectly affect its function. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide modulates the expression of various cytokines and growth factors. If CCDC178 is part of cytokine-regulated pathways, Thalidomide might have an indirect influence. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor. Similar to Bortezomib, it could indirectly affect CCDC178 function if the protein is involved in protein degradation or ubiquitin-dependent processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K. By modulating PI3K activity, it might indirectly affect pathways or processes where CCDC178 is involved. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which could indirectly affect CCDC178 activity if the protein is involved in the MAPK/ERK pathway. | ||||||